HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients.

Abstract
Sarcopenia is a recently defined medical condition described as age-associated loss of skeletal muscle mass and function. Recently, a transgenic mouse model was described linking dispersal of the neuromuscular junction caused by elevated agrin degradation to the rapid onset of sarcopenia. These mice show a significant elevation of serum levels of a C-terminal agrin fragment (CAF) compared to wild-type littermates. A series of experiments was designed to ascertain the significance of elevated agrin degradation in the development of human sarcopenia. A quantitative Western blot method was devised to detect CAF in sera of humans. A first trial on consenting blood donors (n=169; age 19-74 years) detected CAF in the limited range of 2.76 ± 0.95 ng/ml. In sarcopenia patients (diagnosed according to clinical and instrumental standards) mean CAF levels were significantly elevated (p=9.8E10-9; n=73; age 65-87 years) compared to aged matched controls. Of all sarcopenia patients, 40% had elevated, non-overlapping CAF levels compared to controls. Evidence is presented for a pathogenic role of the agrin/neurotrypsin system in a substantial subset of sarcopenia patients. These patients are characterized by elevated CAF blood levels compared to aged-matched healthy volunteers suggesting the identification of an agrin-dependent form of sarcopenia. Elevated CAF levels in a large subpopulation of sarcopenic patients suggest the existence of a specific form of sarcopenia for which CAF could become a biomarker and a new target for therapeutic interventions. The feasibility of this approach was demonstrated by the development of a small molecule capable of inhibiting neurotrypsin in vitro and in vivo.
AuthorsStefan Hettwer, Pius Dahinden, Stefan Kucsera, Carlo Farina, Shaheen Ahmed, Ruggero Fariello, Michael Drey, Cornel Christian Sieber, Jan Willem Vrijbloed
JournalExperimental gerontology (Exp Gerontol) Vol. 48 Issue 1 Pg. 69-75 (Jan 2013) ISSN: 1873-6815 [Electronic] England
PMID22433628 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Agrin
  • Biomarkers
  • Peptide Fragments
  • Serine Proteinase Inhibitors
  • Serine Endopeptidases
  • neurotrypsin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging (blood, physiology)
  • Agrin (blood, drug effects)
  • Animals
  • Biomarkers (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Middle Aged
  • Muscle Strength (physiology)
  • Muscle, Skeletal (physiopathology)
  • Peptide Fragments (blood)
  • Sarcopenia (blood, physiopathology)
  • Serine Endopeptidases (physiology)
  • Serine Proteinase Inhibitors (pharmacology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: